# A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

> **NCT07004972** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 50 (estimated)

## Conditions studied

- Symptomatic Obstructive Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** Mavacamten

## Key facts

- **NCT ID:** NCT07004972
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-09-04
- **Primary completion:** 2027-12-13
- **Final completion:** 2027-12-13
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07004972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07004972, "A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07004972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*